Tech Company Financing Transactions
Matrix Genetics Funding Round
Matrix Genetics, based in Seattle, secured investment capital from Avista.
Transaction Overview
Company Name
Announced On
8/30/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The amount of the investment isn't being disclosed, but it's enough for Matrix to spin out of its parent company, Targeted Growth, and to find new labs in South Lake Union with room for about 15 employees.
Company Information
Company Status
Private & Independent
Industry
Clean Tech
Mailing Address
1600 Fairview Ave. E 300
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Not Recorded
Overview
Matrix Genetics is a biotechnology company focused on producing renewable fuel and specialty chemicals derived from cyanobacteria (blue-green algae).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Margaret McCormick
Chief Scientific Officer
James Roberts
Browse more venture capital transactions:
Prev: 8/30/2012: Celator Pharmaceuticals venture capital transaction
Next: 8/30/2012: Intarcia Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs